Search Videos and More
Fox Chase Researchers Present Data on Integrating Palliative Care Education Into Hematology-Oncology Fellowships
A new integrated palliative care rotation for hematology/oncology fellows improved their palliative care knowledge and skill confidence, according to results of a pilot study presented today by Fox Chase Cancer Center researchers at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.Mapping a Path to Clinical Trials: Bringing Fox Chase’s Innovative Care to the Temple Community
Clinical trials are among the most important resources when it comes to effectively treating challenging cases of cancer, but at Fox Chase Cancer Center, these trials encompass much more than just testing new drug candidates that may be more effective alternative treatments.A One-Stop Shop for Liver Cancer
Fox Chase Improves Treatment and Access to ItComprehensive Cancer Care Demands Exceptional Teamwork, Collaboration and Leaders to Bring It to Life.
Centralizing scientific discovery, advanced research, and clinical care—all for a new therapeutic pathway.New Fox Chase Clinical Trial Could Help Men With Intermediate-Risk Prostate Cancer Avoid Radical Treatment
Could NanoKnife be the future of prostate cancer care?A Salvage Treatment Jennifer Was Inspired to Salvage.
A Life-Saving Idea for Bladder Cancer Patients.Fox Chase Cancer Center Researchers Present Further Data on Potential Bladder-Sparing Treatment
Bladder removal is life-altering. This study examines when and why some patients may not need it.The New Department of Urology at Fox Chase Cancer Center
Built on strength: world-class specialists, innovative researchers, and clinical leaders.Transforming Cancer Care and Delivery
The new President and CEO of Fox Chase Cancer CenterResearch on Making Cancer “Catch” the Flu Wins International Acclaim in Nature
Turning a "cold" tumor "hot" to fight advanced melanoma.A $1.4 Million Grant Looks at Prostate Cancer Through a ‘Neighborhood Lens.’
Where a man is born, lives and works can influence his prostate cancer diagnosis, treatment, and survival. But which factors matter most? And what role do they all play together in how he responds to cancer treatment?For Recurrent Gyn Cancer, Immunotherapy is Becoming a Powerful Treatment Option
Gynecologic cancers that recur are typically treated as chronic diseases. Increasingly, oncologists at Fox Chase Cancer Center are turning to immunotherapy as a powerful option for chronic endometrial, cervical, and ovarian cancer management.

